| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.20B | +37.3% |
| Cost of Revenue | $900.2M | +42.1% |
| Gross Profit | $296.3M | +24.4% |
| R&D Expense | $61.5M | +19.8% |
| SG&A Expense | $47.4M | +28.4% |
| Operating Income | $75.5M | +68.4% |
| Pre-tax Income | $85.3M | +58.1% |
| Income Tax | $18.3M | +87.6% |
| Net Income | $66.9M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $320.9M | +55.9% |
| Accounts Receivable | $102.3M | -14.6% |
| Current Assets | $441.3M | +27.7% |
| Total Assets | $667.9M | +15.9% |
| Current Liabilities | $98.8M | +21.2% |
| Total Liabilities | $107.5M | +18.6% |
| Stockholders' Equity | $560.4M | +15.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $162.1M | +154.8% |
| Capital Expenditures | $361K | -21.0% |
| Investing Cash Flow | -$36.5M | +0.7% |
| Financing Cash Flow | -$10.6M | -5009.7% |
| Free Cash Flow | $161.8M | +156.1% |
| +51.5% |
| EPS (Basic) | $0.53 | +47.2% |
| EPS (Diluted) | $0.52 | +48.6% |